M Gurnell
Overview
Explore the profile of M Gurnell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
735
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Westacott R, Badger K, Kluth D, Gurnell M, Reed M, Sam A
BMC Med Educ
. 2023 Sep;
23(1):659.
PMID: 37697275
Background: Automated Item Generation (AIG) uses computer software to create multiple items from a single question model. There is currently a lack of data looking at whether item variants to...
2.
Annamalai A, Srinivasan K, Gurnell M
Eur J Intern Med
. 2023 Mar;
111:117-118.
PMID: 36914538
No abstract available.
3.
Brown C, Badger K, Reid M, Westacott R, Gurnell M, Reed M, et al.
Med Teach
. 2022 Jul;
44(11):1277-1282.
PMID: 35820076
Background: We have previously shown that clinical examiners' scoring is not negatively impacted when a candidate has a tattoo, unnatural hair colour, or a regional accent. We investigated whether these...
4.
Bashari W, Gillett D, MacFarlane J, Powlson A, Kolias A, Mannion R, et al.
Pituitary
. 2022 Jun;
25(5):709-712.
PMID: 35666391
Management of Cushing's disease is informed by dedicated imaging of the sella and parasellar regions. Although magnetic resonance imaging (MRI) remains the investigation of choice, a significant proportion (30-50%) of...
5.
Bashari W, van der Meulen M, MacFarlane J, Gillett D, Senanayake R, Serban L, et al.
Pituitary
. 2022 May;
25(4):573-586.
PMID: 35608811
Purpose: To assess the potential for C-methionine PET (Met-PET) coregistered with volumetric magnetic resonance imaging (Met-PET/MR) to inform clinical decision making in patients with poorly visualized or occult microprolactinomas and...
6.
7.
Gurnell M, Heaney L, Price D, Menzies-Gow A
J Intern Med
. 2021 Feb;
290(2):240-256.
PMID: 33598993
Secondary adrenal insufficiency (AI) occurs as the result of any process that disrupts normal hypothalamic and/or anterior pituitary function and causes a decrease in the secretion of steroid hormones from...
8.
Sam A, Reid M, Thakerar V, Gurnell M, Westacott R, Yeates P, et al.
Med Teach
. 2021 Feb;
43(5):554-559.
PMID: 33569973
Background: Assessments of physician competence in the work-place are common and often contribute to high-stakes assessments. Previous research suggests that assessors' judgements can be influenced by candidates' physical attributes. We...
9.
Casey R, Giger O, Seetho I, Marker A, Pitfield D, Boyle L, et al.
Semin Oncol
. 2018 Sep;
45(3):151-155.
PMID: 30262398
Context: Metastatic adrenocortical carcinoma (ACC) is an aggressive malignancy with a poor prognosis and limited therapeutic options. A subset of ACC is due to Lynch syndrome, an inherited tumor syndrome...
10.
Annamalai A, Gill A, Shinto A, Sivakumar R, Singhi P, Prabhu V, et al.
QJM
. 2018 Jan;
111(6):421-422.
PMID: 29319792
No abstract available.